Urogen Pharma Stock Pattern Recognition Three Inside Up or Down
| URGN Stock | USD 21.35 0.83 4.04% |
| Symbol |
Recognition |
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The function generated a total of one valid pattern recognition events for the selected time horizon. The Three Inside Up/Down pattern can help to describe an approach of bearish market for UroGen Pharma.
UroGen Pharma Technical Analysis Modules
Most technical analysis of UroGen Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for UroGen from various momentum indicators to cycle indicators. When you analyze UroGen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About UroGen Pharma Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of UroGen Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of UroGen Pharma based on widely used predictive technical indicators. In general, we focus on analyzing UroGen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build UroGen Pharma's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of UroGen Pharma's intrinsic value. In addition to deriving basic predictive indicators for UroGen Pharma, we also check how macroeconomic factors affect UroGen Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 1.44 | 0.81 | 0.73 | 0.5 | Days Of Inventory On Hand | 221.2 | 379.22 | 436.1 | 537.45 |
Align your values with your investing style
In addition to having UroGen Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 90 shares | |
 | SRI Sustainable Growth Invested over 90 shares | |
 | ESG Investing Sold few shares | |
 | Tech Growth Invested over 90 shares | |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UroGen Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in UroGen Stock, please use our How to Invest in UroGen Pharma guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Will Biotechnology sector continue expanding? Could UroGen diversify its offerings? Factors like these will boost the valuation of UroGen Pharma. If investors know UroGen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every UroGen Pharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (3.47) | Revenue Per Share | Quarterly Revenue Growth 0.09 | Return On Assets | Return On Equity |
Investors evaluate UroGen Pharma using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating UroGen Pharma's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause UroGen Pharma's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between UroGen Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if UroGen Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, UroGen Pharma's market price signifies the transaction level at which participants voluntarily complete trades.